![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/05/04/delic_holdings_inc__ketamine_wellness_centers__kwc__introduces_n.jpg)
Delic Holdings Corp.’s (OTCQB:DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.
Starting on May 9, the clinics in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson will introduce the new therapy to their offerings.
NAD+ is a fundamental coenzyme found in every cell of the body thought to have multiple beneficial effects, especially in maintaining cell health. The problem is that with age NAD+ levels naturally decrease.
Currently, there are numerous brands that sell the molecule as a supplement, such as Tru Niagen, Bulletproof, Theagehack and UltraNMN, but the offering for intravenous or intramuscular administration is much lower.
"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being,” commented Kevin Nicholson, CEO of Delic and KWC.